COMMUNIQUÉS West-GlobeNewswire

HealthEdge Named to TIME Magazine’s 2026 List of the World’s Top HealthTech Companies
17/09/2026
Recognition marks second consecutive year HealthEdge has been honored for advancing healthcare through technology BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- HealthEdge ® , the AI-powered operational infrastructure for [...]
Integrity Urgent Care Clinic Opens in White Oak, Texas
17/09/2026
White Oak’s newest urgent care clinic offers accessible, high-quality health care you can count on Key facts of this press release: Integrity Urgent Care opened a clinic in White Oak, Texas, on September 14, 2026 New [...]
NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates
17/09/2026
DENVER, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies (NASDAQ: NTHI) just removed a potentially significant overhang from its capital structure, redeeming all 6,000 outstanding shares of [...]
BayCare Names Brendan Malik, MD, Vice President of Physician Enterprise Development and Chief Medical Officer
17/09/2026
CLEARWATER, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- BayCare has named Brendan Malik, MD, vice president of Physician Enterprise Development and chief medical officer, a newly established role that will help provide [...]
Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
17/09/2026
Dr. Spiegel brings decades of global clinical development, regulatory and oncology leadership experience, including former Chief Medical Officer roles at Schering-Plough and PTC Therapeutics Appointment further [...]
Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
17/09/2026
Findings Strengthen Telomir-Zn’s Oncology-Focused Platform While Demonstrating Broader Relevance of Its Metal-Dependent Epigenetic Biology MIAMI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ [...]
Emanate Receives FDA 510(k) Clearance for Perio PODS™, the First FDA-Cleared At-Home Periodontal Wound Dressing Indicated Following Non-Surgical Periodontal Procedures
17/09/2026
Perio PODS addresses a longstanding treatment gap in clinician-directed at-home periodontal care NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Emanate Biomedical, Inc. , a medical technology company creating a new [...]
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
17/09/2026
Justin Mennen to Succeed Leslie C.G. Campbell as Chair of the Board Following Her Retirement DELRAY BEACH, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx ( [...]
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
17/09/2026
Protocol Submitted for IRB Review at a Leading Cancer Research Institution, Advancing the Study Toward Site Initiation MIAMI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the " [...]
Sienna Continues Platform Growth in Ontario
17/09/2026
MARKHAM, Ontario, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has entered into a purchase agreement to acquire Stonemont On the Park [...]
PharmAla Biotech Provides Corporate Update: Change of Auditor, Retention of Watertower Research and Oak Hill
17/09/2026
TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
17/09/2026
– Late-Breaking Data to Include HOPE-3 Delayed-Start and Natural History Analyses Submitted in the Recent Major Amendment to the Deramiocel BLA – – PDUFA Target Action Date of November 22, 2026 – SAN DIEGO, Sept. 17, [...]
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
17/09/2026
Last patient has completed the last scheduled study visit in the pivotal Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome Top-line results remain on track for late November 2026 NESS ZIONA, [...]
TOMI’s SteraMist Integrated System (SIS) Strategy Converts to Orders: Enclosure Sales Reach $2.3 Million YTD
17/09/2026
Standardized SIS Selling Packages Accelerate Closings and Retrofits, with Recent Purchase Orders slated for Q3-Q4 revenue recognition. SteraBox aimed at recycling, electronics refurbishment, and circular-economy use. [...]
Commure Named to TIME's World’s Top HealthTech Companies for Second Consecutive Year
17/09/2026
In the AI & Data Analytics category, Commure earned recognition for outstanding performance MOUNTAIN VIEW, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today [...]
Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma
17/09/2026
Chief Commercial Officer Bryan Downey Joins Panel Discussion on Reinventing the Launch Playbook for Small and Mid-Size Pharma KANSAS CITY, Kan., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a [...]
Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
17/09/2026
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy [...]
First Insight Corporation Launches The Focal Point Podcast
17/09/2026
Monthly conversations on where AI is changing healthcare, where it falls short, and what responsible innovation looks like PORTLAND, Ore., Sept. 17, 2026 (GLOBE NEWSWIRE) -- First Insight Corporation launched The Focal [...]
Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory Board
17/09/2026
Appointment supports Aerska's progression of its antibody-oligo conjugate platform and growing pipeline of RNA therapeutics for CNS disease Laura brings decades of leadership in developing complex genetic medicines from [...]

Pages

Other news

Promaxo Announces Closing of Series C Financing and $100M Credit Facility

The growth capital will expand manufacturing capacity, reduce backlog, and support new regulatory filings

ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update

WINSTON-SALEM, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp.

BreathiZen Introduces BreathiZen Spray - A New Multi-Ingredient Dietary Supplement For Your Respiratory Wellness

BreathiZen is a once-daily oral spray that brings together botanical extracts, an enzyme preparation, and selected nutrients in a 60 ml bottle designed to fit easily into an adult wellness routine.

New York, Oct. 22, 2026 (GLOBE NEWSWIRE) --

RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026

Company to host conference call on November 5, 2026, at 4:30 p.m. ET

BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET

PALO ALTO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc.

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment

Leadership discusses recent FDA engagement, the technology underlying ERNA-101 and the development strategy supporting planned first-in-human clinical evaluation

SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary, NeuroThera Labs Inc.